首页> 外文期刊>European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) >Quality of life and swallowing with standard chemoradiotherapy versus accelerated radiotherapy and panitumumab in locoregionally advanced carcinoma of the head and neck: A phase III randomised trial from the Canadian Cancer Trials Group (HN.6)
【24h】

Quality of life and swallowing with standard chemoradiotherapy versus accelerated radiotherapy and panitumumab in locoregionally advanced carcinoma of the head and neck: A phase III randomised trial from the Canadian Cancer Trials Group (HN.6)

机译:用标准化学疗法的生活质量和吞咽促进放疗和颈部型头颈癌的加速放疗和Panitumumab:来自加拿大癌症试验组的III期随机试验(HN.6)

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Aim: To compare quality of life (QOL) between standard (SFX) chemoradiotherapy (arm A) and altered fractionation radiotherapy (AFX) with panitumumab (PMab; arm B).
机译:目的:将标准(SFX)化学疗法(ARM A)与Panitumumab(PMAB; ARM B)的改变分馏放疗(AFX)之间的寿命质量(QOL)进行比较。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号